JVMSX | PCMSX | JVMSX / PCMSX | |
Total Expense Ratio | 1.25 | 0.63 | 198% |
Annual Report Gross Expense Ratio | 1.26 | 0.65 | 194% |
Fund Existence | 13 years | 6 years | - |
Gain YTD | 2.313 | -0.706 | -328% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 21.5B | 2.41B | 894% |
Annual Yield % from dividends | 0.43 | 1.41 | 31% |
Returns for 1 year | -3.29 | -9.05 | 36% |
Returns for 3 years | 15.80 | 2.23 | 709% |
Returns for 5 years | 50.13 | 35.25 | 142% |
Returns for 10 years | 33.43 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
LHCSX | 18.21 | -0.10 | -0.55% |
Lord Abbett Health Care R4 | |||
JLCVX | 70.98 | -0.89 | -1.24% |
JHancock Fundamental Large Cap Core R5 | |||
FIIAX | 21.65 | -0.31 | -1.41% |
Fidelity Advisor Mid Cap II A | |||
GMXRX | 14.84 | -0.23 | -1.53% |
Nationwide Mid Cap Market Idx R | |||
KGDIX | 30.79 | -0.49 | -1.57% |
DWS Global Small Cap Inst |